PUBLISHER: The Business Research Company | PRODUCT CODE: 1942838
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942838
An external pacemaker is a medical device used to temporarily regulate a patient's heart rate and cardiac output by delivering electrical pulses to the heart via electrodes attached to a patch placed on the chest. These devices are commonly employed to stabilize patients or to provide support during surgical procedures.
The main product types of external pacemakers included are single chamber and dual chamber. Single-chamber external pacemakers are devices that utilize one lead to deliver electrical impulses to regulate the heart's rhythm. It is provided for applications such as bradycardia, and acute myocardial infarction. These devices are used by end-users such as hospitals, ambulatory surgical centers, and others.
Tariffs have influenced the external pacemakers market by increasing the cost of imported electronic components, batteries, and precision control systems used in pacing devices. These impacts are most evident in hospitals and ambulatory surgical centers across regions reliant on international supply chains, particularly asia-pacific and europe. Higher procurement costs have affected pricing and replacement cycles for temporary pacing systems. However, tariffs are also encouraging local manufacturing, supplier diversification, and cost-optimized device designs, supporting long-term supply resilience.
The external pacemakers market research report is one of a series of new reports from The Business Research Company that provides external pacemakers market statistics, including external pacemakers industry global market size, regional shares, competitors with a external pacemakers market share, detailed external pacemakers market segments, market trends and opportunities, and any further data you may need to thrive in the external pacemakers industry. This external pacemakers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The external pacemakers market size has grown strongly in recent years. It will grow from $1.6 billion in 2025 to $1.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rising incidence of bradycardia, increasing prevalence of acute myocardial infarction, growth in cardiac surgical procedures, expanding emergency medical services infrastructure, increased availability of cardiac critical care units.
The external pacemakers market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising burden of cardiovascular diseases, growing aging population, increasing demand for temporary cardiac pacing solutions, expansion of advanced cardiac care facilities, improving access to emergency and critical care services. Major trends in the forecast period include increasing use of external pacemakers in emergency cardiac care, rising adoption of temporary cardiac pacing in surgical settings, growing demand for portable and user-friendly external pacemakers, increasing preference for dual chamber external pacemakers, rising focus on rapid cardiac stabilization in acute care.
The growing incidence of cardiovascular diseases are expected to drive the growth of the external pacemaker market going forward. Cardiovascular disease (CVD) is a class of diseases involving the heart or blood vessels. There is a growing incidence of cardiovascular diseases due to several factors such as sedentary lifestyles, poor dietary habits high in processed foods and sugars, increasing rates of obesity, smoking, high blood pressure, and stress. The external pacemakers are used in cardiovascular diseases to regulate abnormal heart rhythms and improve cardiac function. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, accounting for approximately one in every three deaths. Therefore, the growing incidence of cardiovascular diseases is expected to propel the growth of the external pacemaker market.
The increasing healthcare expenditure is expected to propel the growth of the external pacemaker market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services within a specific period, typically on a national or institutional level. Investment in healthcare can support research and development efforts in the field of external pacemaker leading to an advancements in technology, improved access to device, and a more comprehensive approach to individuals health and healthcare systems. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, U.S. healthcare expenditures in 2023 rose by 7.5%, reaching $4.9 trillion, or approximately $14,570 per individual. Therefore, the increasing healthcare expenditure is driving the growth of the external pacemaker market.
Major companies operating in the external pacemaker market are developing innovative products, such as miniaturized pacemakers, to improve battery life and gain a competitive edge in the market. Miniaturized or leadless pacemakers are small electronic devices implanted in the heart to regulate its rhythm. For instance, in May 2023, Medtronic Plc, an Ireland-based medical device company, received Food and Drug Administration approval for Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. They provide up to 40% more battery life than previous models, with projected median battery life ranging from nearly 16 to 17 years. These devices feature advanced algorithms for automatic AV synchrony programming and higher tracking capability for active patients. Micra pacemakers minimize complications and improve the patient experience with their small size and lack of leads or surgical pockets.
Major companies operating in the external pacemakers market are ZOLL Medical Corporation, Shree Pacetronix Ltd, Osypka Medical Inc, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Lepu Medical Technology Co Ltd, Biotronik SE & Co KG, LivaNova PLC, MicroPort CRM, Nihon Kohden Corporation, BPL Medical Technologies, Schiller AG, Progetti Medical Equipment Solutions, Instramed Industria Medico Hospitalar, Corpuls GmbH, Skanray Technologies Ltd, Bexen Cardio, CU Medical Systems Inc, Advanced Instrumentations
North America was the largest region in the external peacemakers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the external pacemakers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the external pacemakers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The external pacemakers market consists of sales of MRI-compatible pacemakers and conventional pacemakers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
External Pacemakers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses external pacemakers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for external pacemakers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The external pacemakers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.